News
Geron finally brings a drug to market as FDA clears Rytelo
More than 30 years after it was first founded, Geron has claimed FDA …
19724 items found
News
Italy starts probe into Lucentis biosimilar delay allegation
Italy’s antitrust authority has launched an investigation against …
Sales & Marketing
At BIO 2024, an industry vows to reclaim its narrative
It’s hard to imagine a better spokesperson for BIO 2024’ s message …
Sales & Marketing
Partner Content
PM Society Digital Awards – 12th September 2024 - Tickets Now on Sale!
The PM Society Digital Awards have cemented their place as an …
News
Telix prices $200m IPO in big week for radiopharma financing
Australian radiopharmaceutical specialist Telix has revealed the …
News
Buoyed by new obesity data, Structure files $476m offering
Riding high from positive clinical trial results for its oral …
News
Amgen preps Uplizna filing for a second indication
Amgen has moved closer to a second indication for its B …
News
CDC recommends first post-exposure antibiotic for STIs
Faced with a dramatic rise in sexually transmitted infections, …
News
Mexican man dies in first human case of H5N2 bird flu
A man in Mexico has died in what the World Health Organization (WHO) …
News
PHTI backs virtual therapies for musculoskeletal disorders
A new report from the Peterson Health Technology Institute has …
Digital
News
Gilead, Ipsen build the case for their PBC drugs at EASL
Gilead Sciences is just a few weeks away from an FDA decision on …
Patients
Gilead's HIV success and controversy: Expanding access amid ...
Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly effective medicine.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
Access to genomic surveillance: Open science and public heal...
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
Patients
Partner Content
How walking in a patient's shoes adds value to your patient ...
Imagine the difference it would make if everyone in your organisation had firsthand experience of living with one of the conditions you help treat. What insights would you gain?
R&D
Partner Content
BIO-Europe's 30th Anniversary Landmark Event in Stockholm
BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
